Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$11.93
+3.65%
Mkt Cap $261.88M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
Implied Upside
+304.0%
Consensus $48.20 vs current $11.93
NASDAQ·Healthcare·Biotechnology
$11.93
+3.65%
Mkt Cap $261.88M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
+304.0%
Consensus $48.20 vs current $11.93